Cancer Theranostics, Second Edition - Hardcover

 
9780443222535: Cancer Theranostics, Second Edition

Synopsis

Cancer Theranostics, Second Edition provide updates on new molecular imaging probes and techniques for early detection of cancer and describes molecular imaging-guided cancer therapy. Discussions also include nanoplatforms, incorporating both cancer imaging and therapeutic components, as well as clinical translation and future perspectives. New to this edition is the inclusion of recent developments and a streamlined structure that leads the reader through the content more intuitively, from problem to solution. More illustrations of different forms of cancer theranostics​ are included, and this edition also contains completely new content on DNA and RNA theranostics. In addition, new case studies are featured.

This new edition is published in time to meet the needs of medical researchers in a comprehensive manner, encompassing diagnostics, in vivo imaging and its use for image-guided therapy, and a variety of other miscellaneous subjects. This book is a must-have for all research scientists, medical physicists, and physician scientists in cancer experimental therapeutics and molecular imaging.

  • Describes the identification of novel biomarkers to advance molecular diagnostics of cancer
  • ​Includes the latest developments in liquid biopsy, new imaging techniques such as magnetic particle imaging, artificial intelligence, different types of image-guided interventions and drug delivery, and new forms of theranostics, including the most recent mRNA based theranostics
  • ​Gives various, novel forms of cancer interventions and treatments
  • ​Provides clinical translation of different types of cancer theranostics platforms

"synopsis" may belong to another edition of this title.

About the Authors

Xiaoyuan (Shawn) Chen, PhD, is a Senior Investigator and Chief of the Laboratory of Molecular Imaging and Nanomedicine (LOMIN) at the National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH). He is also founding editor of journal Theranostics. He holds a PhD in Chemistry from the University of Idaho.

Dr. Zhang is Assistant Professor (Tenure Track) at the Yong Loo Lin School of Medicine, National University of Singapore. She has published more than 50 peer-reviewed articles (more than 15 peer-reviewed articles in top-ranking journal JNM) in the most reputed scientific journals in the respective field. She was awarded the prestigious Thomas O’Dorisio Young Investigator Award (only 1 awardee every two years world-wide), one of TOP thirty early career professionals who stand out as “Ones to Watch” by the SNMMI, as well as Majd-Gilday Investigator Award from SNMMI, etc., and serves on the editorial board of Clin Nucl Med (IF 10.782) and is the only editorial board member from Singapore. She currently serves as Dean of Research of International Centers for Precision Oncology (ICPO) Academy, Germany

Stephen T.C. Wong, PhD (Computer Science), PE (Electrical Engineering), is John S. Dunn Distinguished Endowed Chair of Biomedical Engineering at Houston Methodist Hospital, the Founding Chair of Department of Systems Medicine and Bioengineering at Houston Methodist Research Institute, and a Professor of Radiology, Neurosciences, Pathology, and Laboratory Medicine at Weill Cornell Medical College.

From the Back Cover

Cancer Theranostics, Second Edition continues to provide current and concise information making ita readily available reference for the identification of novel biomarkers to advance molecular diagnostics of cancer.

The new ediiton encompasses new molecular imaging probes and techniques for early detection of cancer and describes molecular imaging-guided cancer therapy. Discussion also includes nanoplatforms incorporating both cancer imaging and therapeutic components, as well as clinical translation and future perspectives. New to this edition is the inclusion of recent developments, the streamlined structure of the chapters leading the reader through the content more intuitively from problem to solution. More illustrations of different forms of cancer theranostics​ are included and this edition also hold completely new content on DNA and RNA theranostics. New features in this title are several case studies.

In five sections and 26 chapters Cancer Theranostics, Second Edition, reviews, assesses, and makes pertinent clinical recommendations on the integration of comprehensive in vitro diagnostics, in vivo molecular imaging, and individualized treatments towards the personalization of cancer treatment.

This new edition is published in time to meet the needs of medical researchers in a comprehensive manner encompassing diagnostics, in vivo imaging and its use for image-guided therapy, and a variety of other miscellaneous subjects. This book is a must-have for all research scientist, medical physicists and physician scientists in cancer experimental therapeutics and molecular imaging.

"About this title" may belong to another edition of this title.